Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
The American Journal of Surgical Pathology|October 19, 1999
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumorsV A Marcus, L Madlensky, R Gryfe, et al.British Journal of Cancer|July 17, 2015
BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenograftsI Lohse, A Borgida, P Cao, et al.Carcinogenesis|October 19, 2007
MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancerMiralem Mrkonjic, Stavroula Raptis, Roger C Green, et al.Cell|August 23, 1996
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinomaK Eppert, S W Scherer, H Ozcelik, et al.British Journal of Cancer|July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersT Golan, Z S Kanji, R Epelbaum, et al.Gene Therapy|August 6, 1999
Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trialA K Stewart, N J Lassam, I C Quirt, et al.Journal of the National Cancer Institute|March 22, 2007
MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancerStavroula Raptis, Miralem Mrkonjic, Roger C Green, et al.British Journal of Cancer|May 19, 2011
Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patientsJ B Rawson, M Mrkonjic, D Daftary, et al.Human Genetics|April 6, 1999
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancerB V Bapat, L Madlensky, L K Temple, et al.Clinical Genetics|December 16, 2010
Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndromeL Raskin, F Schwenter, M Freytsis, et al.Pageof 15